Circulating Tumor Cells in Oral Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Accurate prognosis for oral squamous cell carcinoma (OSCC) is lacking. Developing a reliable blood marker is crucial for predicting patient survival and guiding treatment decisions for better outcomes.
Area Of Science
- Oncology
- Cancer Biomarkers
Background
- Current oral squamous cell carcinoma (OSCC) grading lacks prognostic value.
- Prognosis is significantly impacted by lymph node metastases, surgical margins, and vascular invasions.
- Existing prognostic methods often rely on invasive techniques or post-surgical analysis.
Purpose Of The Study
- To highlight the need for a dependable blood marker for OSCC prognosis.
- To emphasize the requirement for non-invasive screening and monitoring techniques.
- To underscore the importance of accurate prognosis for patient survival and treatment planning.
Main Methods
- Review of current OSCC grading systems and their limitations.
- Discussion of prognostic factors including lymph node metastases and vascular invasion.
- Exploration of the potential of blood-based markers for detecting tumor cell dissemination.
Main Results
- Traditional OSCC grading does not predict patient prognosis effectively.
- Lymph node metastases significantly impact patient survival (50%).
- Dissemination of tumor cells into the bloodstream is a key event in metastasis.
Conclusions
- A dependable blood marker is essential for accurate OSCC prognosis, especially for loco-regional and distant recurrence.
- Non-surgical, reliable techniques are needed to assess tumor progression and guide treatment.
- Integrating oral health impact assessments can improve quality of life for OSCC patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...